Skip to the page

Data / Drug companies / Decitabine

Decitabine: 18 companies and 22 products in the FDA NDC directory

Decitabine is listed in the FDA National Drug Code Directory by 18 companies, with 22 products in commercial distribution. 21 of the products (95.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, lyophilized, for solution; kit, and the newest product started marketing on September 29, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
18
Products
22
Generic (ANDA) products
21 (95.5%)
Application numbers
13
Routes
Intravenous
openFDA record search
api.fda.gov

Companies that list decitabine

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
BluePoint Laboratories3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 29, 2026
Meitheal Pharmaceuticals Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 2, 2021
Novadoz Pharmaceuticals LLC2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)March 2, 2020
Accord Healthcare Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)March 8, 2017
Amneal Pharmaceuticals LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 1, 2019
Bryant Ranch Prepack1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 28, 2019
Camber Pharmaceuticals, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 10, 2024
Dr. Reddy's Laboratories Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 5, 2014
Dr. Reddy's Laboratories Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 11, 2013
Eugia US LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 20, 2021
Gland Pharma Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 23, 2020
Hikma Pharmaceuticals USA Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 15, 2022
Mylan Institutional LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 10, 2018
Nivagen Pharmaceuticals, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 17, 2020
NorthStar RxLLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 17, 2020
Qilu Pharmaceutical Co., Ltd.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 12, 2021
Sagent Pharmaceuticals1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2023
Sun Pharmaceutical Industries, Inc.1kitNew drug applications (NDA)January 24, 2014

Dosage forms

Dosage formProductsShare
Injection, powder, lyophilized, for solution2195.5%
Kit14.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)2195.5%
New drug applications (NDA)14.5%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.